- Report
- August 2026
- 197 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 180 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 188 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 198 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 181 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- November 2025
- 180 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- February 2026
- 200 Pages
United States
From €2682EUR$2,990USD£2,293GBP
- Report
- August 2021
- 183 Pages
Global
From €3992EUR$4,450USD£3,413GBP
- Report
- October 2025
- 98 Pages
Kuwait
From €4037EUR$4,500USD£3,451GBP

Molecular Pathology is a sub-discipline of Molecular Diagnostics that focuses on the use of molecular techniques to diagnose and monitor diseases. It involves the analysis of genetic material, such as DNA and RNA, to identify mutations and other changes that can be used to diagnose and monitor diseases. Molecular Pathology is used to diagnose a wide range of diseases, including cancer, infectious diseases, and inherited disorders. It is also used to monitor the progression of diseases and to determine the effectiveness of treatments.
Molecular Pathology is a rapidly growing field, with advances in technology allowing for more accurate and cost-effective diagnosis and monitoring of diseases. It is increasingly being used in clinical settings to improve patient care and outcomes.
Some companies in the Molecular Pathology market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more